Retour à la carte
australia
FIND
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Development of a serological rapid test for risk of P. vivax relapse
A host antibody marker of past P. vivax infection is targeted in a lateral flow assay in development by Mologic (UK). Clinical studies with partners in Indonesia and Australia will evaluate the assay performance in two longitudinal cohort studies monitoring P. vivax clinical exposure and relapse events.
Pays
indonesia united-kingdom japan australia
Impact
1,180 persons
Durée
2015 - ongoing
Activité
Innovation,Diagnosis